ALARIS Medical Announces Agreement With Global Healthcare Exchange.Business Editors & Health/Medical Writers SAN DIEGO--(BW HealthWire)--Feb. 19, 2002 ALARIS Medical Inc. (AMEX AMEX See: American Stock Exchange :AMI) announced today that its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , ALARIS Medical Systems Inc., has signed a one-year agreement to join Global Healthcare Exchange LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control (GHX GHX Global Healthcare Exchange GHX Ground Heat Exchanger ) as a supplier member in the U.S. market segment starting in the first quarter of 2002. This agreement with GHX, an Internet-based, business-to-business e-health trading exchange for the purchase, sale and distribution of medical equipment, provides ALARIS Medical with the technologies required to increase efficiencies and reduce costs by providing and updating product information via one connection available to all GHX hospital members. With information provided and transactions confirmed and tracked automatically, ALARIS Medical will be able to ensure continued improving product fulfillment and resource planning. Jake St. Philip, vice president and general manager of ALARIS Medical Systems' North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. Business Unit, said, "GHX gives us the ability to serve a significant segment of our hospital customers directly with fast delivery response. GHX's robust online catalog will assist ALARIS Medical in continuing to improve its service to its hospital members by improving the efficiency of healthcare delivery through information exchange and by maximizing efficiencies in the supply chain." Brent Ness, executive, supplier market development for GHX, said, "We are thrilled to welcome ALARIS Medical Inc. to our team of supplier members. ALARIS Medical will contribute to enhance our array of medical products, strengthen our online product catalog, and expand our e-procurement marketplace." GHX has recently announced plans to broaden the exchange with several group purchasing organization A group purchasing organization is an entity that leverages the purchasing power of a group of businesses to obtain discounts from vendors based on the collective buying power of the GPO members. Many GPOs are funded by administrative fees that are actually paid by the vendors. (GPO) partnerships including AmeriNet and Neoforma, and the distributor exchange HealthNexis. These will add to the existing list of key hospital provider IDN's that have already signed with GHX. About ALARIS Medical Inc. ALARIS Medical Inc., through its wholly owned operating company operating company A business that engages in transactions with outsiders. , ALARIS Medical Systems Inc., is a leading developer, manufacturer and provider of integrated intravenous infusion therapy and patient monitoring instruments and related disposables, accessories and services. ALARIS Medical's primary brands, ALARIS(R), IMED IMED International Medical Education Directory (R) and IVAC IVAC Islington Voluntary Action Council (England, UK) IVAC Insert Valid Access Card (satellite TV hacking) IVAC International Video & Audio Convention IVAC Idle Air Control Valve (R), are recognized throughout the world. ALARIS Medical's products are distributed in more than 120 countries worldwide. In addition to its San Diego world headquarters and manufacturing facility, ALARIS Medical also operates manufacturing facilities in Creedmoor, N.C.; Basingstoke, U.K.; and Tijuana, Mexico. Additional information on ALARIS Medical can be found at www.alarismed.com/. About Global Healthcare Exchange Global Healthcare Exchange LLC (GHX) is an Internet-based trading exchange from which hospitals can purchase both medical and non-medical products more easily, quickly, and accurately than ever before. GHX is building a normalized, verified industry standard catalog, which will take advantage of deep connectivity between GHX, hospitals, and suppliers to improve efficiencies and add value throughout the healthcare supply chain. The privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. was founded in March 2000 and its membership now includes more than 100 supplier members and nearly 600 hospital members, representing 70 integrated delivery networks (IDNs). Equity owners of GHX include Johnson & Johnson; GE Medical Systems; Baxter International Inc.; Abbott Laboratories; Medtronic Inc.; AmerisourceBergen Corp.; Becton, Dickinson & Co.; Boston Scientific Corp.; Cardinal Health Inc.; C.R. Bard Inc.; Fisher Scientific International Inc.; Guidant Corp.; McKesson Corp.; Siemens Medical Solutions Siemens Medical Solutions (Siemens Med) is a supplier to the healthcare industry, and is headquartered in Erlangen, Germany. Its U.S. division, Siemens Medical Solutions USA, Inc., is a Delaware corporation, with headquarters in Malvern, Pennsylvania. and Tyco International Ltd. For more information visit www.ghx.com. This news release contains forward-looking statements as defined in the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Persons reading this release are cautioned that such forward-looking statements involve risks and uncertainties, including the effect of legislative and regulatory changes affecting the health care industry, the potential of increased levels of competition, technological changes, the dependence of ALARIS Medical upon the success of new products (including its proprietary Guardrails(TM) Safety Software and the MEDLEY(TM) Medication Safety System) and ongoing research and development efforts including obtaining regulatory approvals, restrictions contained in the instruments governing the Company's indebtedness, and the significant leverage to which the Company is subject. Such risk factors are detailed in the Securities and Exchange Commission filings of ALARIS Medical Inc. and ALARIS Medical Systems Inc., including Forms 10-K for the year ended Dec. 31, 2000, and other filings. The Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion